Rationale and design of a prospective, observational, multicenter study on the safety and efficacy of apixaban for the prevention of thromboembolics in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study - Kartas, A; Doundoulakis, I; Ntiloudi, D (BMJ Open, 2020)
et al.